Linden Capital Partners has acquired Alcresta Therapeutics, Inc.
Overview
Deal Type |
Mergers & Acquisitions |
---|---|
Our Role |
Buy-Side Advisor |
Summary
Cain Brothers, a division of KeyBanc Capital Markets, served as financial advisor to Linden Capital Partners on the acquisition of Alcresta Therapeutics, Inc.
Cain Brothers was engaged to serve as financial advisor to Linden based on its deep expertise and experience in the medical device sector as well as its long-standing relationship with Linden.
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is the country’s largest dedicated healthcare private equity firm by total buyout capital raised. Linden’s strategy is based on three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested in more than 40 healthcare companies encompassing over 325 total transactions. The firm has approximately $8 billion in regulatory assets under management.
Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases. Alcresta currently markets RELiZORB for enterally fed patients (those whose food is delivered directly to the gastrointestinal tract) with pancreatic insufficiency, which occurs in cystic fibrosis, pancreatic cancer, and pancreatitis, and is developing platform applications for patients with short bowel syndrome and prematurely born infants treated in the NICU.
KeyBanc Capital Markets is a trade name under which the corporate and investment banking products and services of KeyCorp and its subsidiaries, KeyBanc Capital Markets Inc., member FINRA/SIPC (“KBCMI”), and KeyBank National Association (“KeyBank N.A.”), are marketed. Securities products and services are offered by KeyBanc Capital Markets Inc. and by its licensed securities representatives. Banking products and services are offered by KeyBank N.A.